Biosensors clarifies reported FDA product ban

21 Jan 2016 - Singapore Business Review
It was caused by administrative errors. Mainboard-listed Biosensors International Group, a developer, manufacturer and marketer of medical devices, has clarified reports stating that the US Food and Drug Administration (FDA) has banned the company from importing products to the US. Biosensors said that ...
sgx:b20

---

The Best Mid-Cap Stocks for the Year

7 Dec 2015 - The Motley Fool Singapore
Tweet Some investors like the safety of big blue chip companies. Some prefer the potential of small companies. And then, there are investors who prefer somewhere in between. For mid-sized companies, a good place to start tracking them could be the FTSE Mid-Cap Index. Not too hot, not too cold As of 30 ...
sgx:s58 sgx:v03 sgx:b20 sgx:n03 sgx:^sti

---

Genting Singapore PLC Leads the Market Higher for the Week

8 Nov 2015 - The Motley Fool Singapore
Tweet The Straits Times Index (SGX: ^STI) ended the week at 3,010 points, inching up just 0.4% since last week’s close of 2,998 points. Of the 30 index components, 18 were in the green while the rest were in the doghouse, with Golden Agri-Resources Ltd (SGX: E5H) losing the most ground. It fell around ...
sgx:es3 sgx:e5h sgx:c6l sgx:g13 sgx:j7x sgx:b20 sgx:^sti

---

CITIC PE offers $0.84 per share for Biosensors acquisition

4 Nov 2015 - Singapore Business Review
It was raised from $0.815 per share. CITIC Private Equity Funds Management Co.’s (CITIC PE) proposal of an amalgamation between CB Medical Holdings Limited (CBMHL) and Biosensors International Group (BIG) has been approved today, according to a report by OCBC. CBMHL revised their offer from from $0.815 ...
sgx:o39 sgx:b20

---

Biosensors hit with $303.6m loss in FY15

28 May 2015 - Singapore Business Review
Blame it on a goodwill impairment. Biosensors International reported a net loss of $303.6m (US$224.8m), compared to a net profit of US$6.1m in the previous financial year. The hefty loss was due to a number of non-exceptional items, including a US$256.1m goodwill impairment for its subsidiary JW Medical ...
sgx:b20

---

The Three Numbers That Have Weakened Biosensors International

12 Mar 2015 - The Motley Fool Singapore
How things have changed at Biosensors International (SGX: B20). Singapore’s flagship biotechnology company that used to boast double-digit Returns on Equity (RoE) has seen the key measure of profitability slump to just 2.3%. The drop in the RoE has, in part, been caused by a fall in efficiency. The company ...
sgx:b20

---

Would Benjamin Graham Buy Biosensors International?

16 Feb 2015 - The Motley Fool Singapore
Biosensors International (SGX: B20) is a medical device company. It specialises in developing and manufacturing technologies for use in treating heart disease. The company’s leading product is a drug-eluting stent that it obtained the right to sell in Europe in 2008. The company will reach its 10th anniversary ...
sgx:b20

---

Biosensors’ net profit plunged 33.2% to $10m in Q3

13 Feb 2015 - Singapore Business Review
Due to lower licensing revenue. Biosensors International reported that its profit after tax and minority interest (PATMI) plunged 33.2% to $10m (US$7.4m) in Q3 on back of lower licensing revenue and adverse forex impact. Total revenue slipped 6% to $105.2m (US$77.5m), compared to $112m (US$82.5m) in ...
sgx:b20

---

Why Has Biosensors International Group Ltd Spiked By 38% in 30 Days?

15 Jan 2015 - The Motley Fool Singapore
Although we don’t believe in focusing too much on short-term market movements, we do like to keep an eye on changes as they might be an indication that some interesting developments may be happening with a company. With Biosensors International Group Ltd (SGX: B20) seeing its shares spiking by 38% over ...
sgx:b20

---

The Singapore Market this Week: Noble Group Limited Leads The Market Lower

21 Dec 2014 - The Motley Fool Singapore
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on changes – just in case they’re material to our investing thesis. The Singapore market, represented by the Straits Times Index (SGX: ^STI), lost 1.3% this week to end at 3,280 points. On Tuesday, ...
sgx:n21 sgx:s51 sgx:b20 sgx:o23 sgx:^sti

---